Cell Therapy for Critical Limb Ischemia: Advantages, Limitations, and New Perspectives for Treatment of Patients with Critical Diabetic Vasculopathy
Crossref DOI link: https://doi.org/10.1007/s11892-021-01378-4
Published Online: 2021-03-02
Published Print: 2021-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gu, Y.
Rampin, A.
Alvino, V. V.
Spinetti, G.
Madeddu, P. http://orcid.org/0000-0002-4718-9205
Text and Data Mining valid from 2021-03-01
Version of Record valid from 2021-03-02
Article History
Accepted: 13 January 2021
First Online: 2 March 2021
Declarations
:
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: The authors declare no competing interests.